Trypanosoma cruzi: Roles for perforin-dependent and perforin-independent immune mechanisms in acute resistance

Experimental Parasitology

Volumn 94, Issue 4, 2000, Pages 207-216

  Nickell, Steven P ^a   Sharma, Divya ^a  

^a UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

Author keywords

CD8+ T cells; Perforin; Perforin dependent cytotoxicity; Protection; Protozoa, parasitic; Survival; T. cruzi, Trypanosoma cruzi

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; CYTOKINE; GAMMA INTERFERON; PERFORIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; CYTOLYSIS; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; FEMALE; IMMUNE RESPONSE; INFECTION RESISTANCE; LYMPHOCYTE DEPLETION; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRYPANOSOMA CRUZI;

EID: 0034130608     PISSN: 00144894     EISSN: None     Source Type: Journal    
DOI: 10.1006/expr.2000.4498     Document Type: Article

References (59)

1. Araujo F. Development of resistance to Trypanosoma cruzi in mice depends on a viable population of L3T4+ (CD4+) T lymphocytes. Infect. Immun. 57:1989;2246-2248.
2. Bloom B. R., Modlin R. L., Salgame P. Stigma variations: Observations on suppressor T cells and leprosy. Ann. Rev. Immunol. 10:1992;453-488.
3. Bosma M. J. The scid mutation: Occurrence and effect. Curr. Topics Micr. Immunol. 152:1989;3-9.
4. Broek M. E. v. d., Kagi D., Ossendorp F., Toes R., Vamvakas S., Lutz W. K., Melief C. J., Zinkernagel R. M., Hengartner H. Decreased tumor surveillance in perforin-deficient mice. J. Exp. Med. 184:1996;1781-1790.
5. Cardillo F., Voltarelli J. C., Reed S. G., Silva J. S. Regulation of Trypanosoma cruzi infection in mice by gamma interferon and interleukin 10: Role of NK cells. Infect. Immun. 64:1996;128-134.
6. Castanos-Velez E., Maerlan S., Osorio L. M., Aberg F., Biberfeld P., Orn A., Rottenberg M. E. Trypanosoma cruzi infection in tumor necrosis factor receptor p55-deficient mice. Infect. Immun. 66:1998;2960-2968.
7. Cooper A. M., D'Souza C., Frank A. A., Orme I. M. The course of Mycobacterium tuberculosis infection in the lungs of mice lacking expression of either perforin- or granzyme-mediated cytolytic mechanisms. Infect. Immun. 65:1997;1317-1320.
8. Farrell J. P., Muller I., Louis J. A. A role for Lyt2+ T cells in resistance to cutaneous leishmaniasis in immunized mice. J. Immunol. 142:1989;2052-2056.
9. Flynn J. L., Goldstein M. M., Triebold K. J., Bloom B. R. Major histocompatibility complex class I-restricted T cells are necessary for protection against M. tuberculosis in mice. Inf. Ag. Dis. 2:1993;259-262.
10. Garcia-Sanz J. A., Plaetinck G., Velotti F., Masson D., Tschopp J., MacDonald H. R., Nabholz M. Perforin is present only in normal activated Lyt2+ T lymphocytes and not in L3T4+ cells, but the serine protease granzyme A is made by both subsets. EMBO J. 6:1987;933-938.
11. Gazzinelli R. T., Oswald I. P., Hieny S., James S. L., Sher A. The microbicidal activity of interferon-γ-treated macrophages against Trypanosoma cruzi involves an L-arginine dependent, nitrogen oxide-mediated mechanism inhibitable by interleukin-10 and transforming growth factor-β Eur. J. Immunol. 22:1992;2501-2506.
12. Germain R. N. Immunology: The ins and outs of antigen processing. Nature. 322:1986;687-689.
13. Goldman D., Cho Y., Zhao M., Casadevall A., Lee S. C. Expression of inducible nitric oxide synthase in rat pulmonary Cryptococcus neoformans granuloma. Am. J. Pathol. 148:1996;1275-1282.
14. Harty J. T., Bevan M. J. CD8+ T cells specific for a single nonamer epitope of Listeria monocytogenes are protective in vivo. J. Exp. Med. 175:1992;1531-1538.
15. Hudig D., Ewoldt G. R., Woodward S. L. Proteases and lymphocyte cytotoxic killing mechanisms. Curr. Opin. Immunol. 5:1993;90-96.
16. Ju S. T., Panka D. J., Cui H., Ettinger R., el-Khatib M., Sherr D. H., Stanger B. Z., Marshak-Rothstein A. Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation. Nature. 373:1995;444-448.
17. Kagi D., Ledermann B., Burk K., Seile P., Odermat B., Olsen K. J., Podack E. R., Zinkernagel R. M. Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice. Nature. 369:1994a;31-37.
18. Kagi D., Ledermann B., Burki K., Hengartner H., Zinkernagel R. M. CD8+ T cell-mediated protection against an intracellular bacterium by perforin-dependent cytotoxicity. Eur. J. Immunol. 24:1994b;3068-3072.
19. Kagi D., Vignaux F., Ledermann B., Burki K., Depraetere V., Nagata S., Hengartner H., Golstein P. Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity. Science. 265:1994c;528-530.
20. Kawasaki A., Shinkai Y., Kuwana Y., Furuya A., ligo Y., Hanai N., Itoh S., Yagita H., Okumura K. Perforin, a pore-forming protein detectable by monoclonal antibodies, is a functional marker for killer cells. Int. Immunol. 2:1990;677-684.
21. Keane-Myers A., Nickell S. P. Role of IL-4 and IFN-γ in modulation of immunity to Borrelia burgdorferi infections in mice. J. Immunol. 155:1995;2020-2028.
22. Kumar S., Tarleton R. L. The relative contribution of antibody production and CD8+ T cell function to immune control of Trypanosoma cruzi. Parasite Immunol. 20:1998;207-216.
23. Kuppers R. C., Simon M. M., Eichmann K. The growth of concanavalin-A activated, Lyt selected subsets in IL-2-containing supernatants. Immunobiology. 167:1984;365-375.
24. Ladel C. H., Daugelat S., Kaufmann S. H. Immune response to Mycobacterium bovis bacille Calmette Guerin infection in major histocompatibility complex class I- and II-deficient knock-out mice: contribution of CD4 and CD8 T cells to acquired resistance. Eur. J. Immunol. 25:1995;377-384.
25. Laochumroonvorapong P., Wang J., Liu C. C., Ye W., Moreira A. L., Elkon K. B., Freedman V. H., Kaplan G. Perforin, a cytotoxic molecule which mediates cell necrosis, is not required for the early control of mycobacterial infection in mice. Infect. Immun. 65:1997;127-132.
26. Ley V., Andrews N., Robbins E., Nussensweig V. Amastigotes of T. cruzi sustain an infective cycle in mammalian cells. J. Exp. Med. 168:1988;649-659.
27. Ley V., Robbins E. S., Nussensweig V., Andrews N. W. The exit of Trypanosoma cruzi from the phagosome is inhibited by raising the pH of acidic compartments. J. Exp. Med. 171:1990;401-413.
28. Lichtenheld M. G., Olsen K. J., Lu P., Lowrey D. M., Hameed A., Hengartner H., Podack E. R. Structure and function of human perforin. Nature. 335:1988;448-451.
29. McCabe R., Meagher S., Mullins B. Gamma interferon suppresses acute and chronic Trypanosoma cruzi infection in cyclosporin-treated mice. Infect. Immun. 59:1991;1633-1638.
30. Mosmann T. R., Sad S. The expanding universe of T cell subsets: Th1, Th2 and more. Immunol. Today. 17:1996;138-146.
31. Mosmann T. R., Sad S., Krishnan L., Wegmann T. G., Guilbert L. J., Belosevic M. Differentiation of subsets of CD4+ and CD8+ T cells. CIBA Found. Symp. 195:1995;42-50.
32. Nickell S. P., Gebremichael A., Hoff R., Boyer M. H. Isolation and functional characterization of T cell lines and clones specific for the protozoan parasite Trypanosoma cruzi. J. Immunol. 138:1987;914-921.
33. Nickell S. P., Keane M. A., So M. Further characterization of protective Trypanosoma cruzi-specific CD4+ T cell clones: T helper 1-like phenotype and reactivity with shed trypomastigote antigens. Infect. Immun. 61:1993a;3250-3258.
34. Nickell S. P., Stryker G. A., Arevalo C. Isolation from Trypanosoma cruzi-infected mice of CD8+, MHC-restricted cytotoxic T cells that lyse parasite-infected targets. J. Immunol. 150:1993b;1446-1457.
35. Plata F., Weirtzerbin J., Pons F., Falcoff E., Eisen H. Synergistic protection by specific antibodies and interferon against infection by Trypanosoma cruzi in vitro. Eur. J. Immunol. 14:1984;930-935.
36. Podack E. R., Young J. D. E., Cohn Z. A. Isolation and biochemical and functional characterization of perforin 1 from cytolytic T-cell granules. Proc. Natl. Acad. Sci. USA. 82:1985;8629-8633.
37. Reed S. G. In vivo administration of recombinant IFN-γ induces macrophage activation, and prevents acute disease, immune suppression, and death in experimental Trypanosoma cruzi infections. J. Immunol. 140:1988;4342-4347.
38. Rottenberg M., Bakhiet M., Olsson T., Kristensson K., Mak T., Wigzell H., Orn A. Differential susceptibilities of mice genomically depleted of CD4 and CD8 to infections with Trypanosoma cruzi or Trypanosoma brucei. Infect. Immun. 61:1993;5129-5133.
39. Rottenberg M., Cardoni R. L., Andersson R., Segura E. L., Orn A. Role of T helper/inducer cells as well as natural killer cells in resistance to Trypanosoma cruzi infection. Scand. J. Immunol. 28:1988;573-582.
40. Rottenberg M. E., Riarte A., Sporrong L., Altcheh J., Petray P., Ruiz A. M., Wigzell H., Orn A. Outcome of infection with different strains of Trypanosoma cruzi in mice lacking CD4 and/or CD8. Immunol. Lett. 45:1995a;53-60.
41. Rottenberg M. E., Sporrong L., Persson I., Wigzell H., Orn A. Cytokine gene expression during infection of mice lacking CD4 and/or CD8 with Trypanosoma cruzi. Scand. J. Immunol. 41:1995b;164-170.
42. Sad S., Kag D., Mosmann T. R. Perforin and Fas killing by CD8+ T cells limits their cytokine synthesis and proliferation. J. Exp. Med. 184:1996;1543-1547.
43. Sanderson C. J., Thomas J. A., Twomey C. E. The growth of Trypanosoma cruzi in human diploid cells for the production of trypomastigotes. Parasitology. 80:1980;153-162.
44. Schofield L., Villaquiran J., Ferriera A., Schellekens H., Nussensweig R., Nussensweig V. Gamma interferon, CD8+ T cells and antibodies required for immunity to malaria sporozoites. Nature. 330:1987;664-666.
45. Silva J. S., Morrissey P. J., Grabstein K. H., Mohler K. M., Anderson D., Reed S. G. Interleukin 10 and interferon-γ regulation of experimental Trypanosoma cruzi infection. J. Exp. Med. 175:1992;169.
46. Silva L. H. P. d., Nussensweig V. Sobre uma cepa de Trypanosoma cruzi altamente virulente para o camundonga branco. Folia Clin. Biol. 20:1953;191-194.
47. Suzuki Y., Remington J. S. Dual regulation of resistance against Toxoplasma gondii infection by Lyt-2+ and Lyt1+, L3T4+ T cells in mice. J. Immunol. 140:1988;3943-3946.
48. Tarleton R. L. Depletion of CD8+ T cells increases susceptiblity and reverses vaccine-induced immunity in mice infected with Trypanosoma cruzi. J. Immunol. 144:1990;717-724.
49. Tarleton R. L., Grusby M. J., Postan M., Glimcher L. H. Trypanosoma cruzi infection in MHC-deficient mice: Further evidence for the role of both class I- and class II-restricted T cells in immune resistance and disease. Int. Immunol. 8:1996;13-22.
50. Tarleton R. L., Koller B. H., Latour A., Postan M. Susceptibility of β2-microglobulin-deficient mice to Trypanosoma cruzi infection. Nature. 356:1992;338-340.
51. Titus R. G., Milon G., Marchal G., Vassali P., Cerottini J. C., Louis J. A. Involvement of specific Lyt2+ T cells in the immunological control of experimentally induced murine cutaneous leishmaniasis. Eur. J. Immunol. 17:1987;1429-1433.
52. Torrico F., Heremans H., Rivera M. T., Marck E. V., Billiau A., Carlier Y. Endogenous IFN-gamma is required for resistance to acute Trypanosoma cruzi infection in mice. J. Immunol. 146:1991;3626-3632.
53. Weiss W. R., Berzofsky J. A., Houghten R. A., Sedegah M., Hollingdale M., Hoffman S. L. A T cell clone directed at the circumsporozoite protein which protects mice against both Plasmodium yoelii and Plasmodium berghei. J. Immunol. 149:1992;2103-2109.
54. Weiss W. R., Sedagah R., Beaudoin R. L., Miller L. H., Good M. F. CD8+ T cells are required for protection in mice immunized with malaria sporozoites. Proc. Natl. Acad. Sci. USA. 85:1988;573-576.
55. Wisseman C. L., Waddell A. Interferonlike factors from antigen-and mitogen-stimulated human leukocytes with antirickettsial and cytolytic actions on Rickettsia prowazekii. Infected human endothelial cells, fibroblasts, and macrophages. J. Exp. Med. 157:1983;1780-1793.
56. Wizel B., Nunes M., Tarleton R. L. Identification of Trypanosoma cruzi trans-sialidase family members as targets of protective CD8+ Tc1 responses. J. Immunol. 159:1997;6120-6130.
57. Wrightsman R. A., Leon W., Manning J. E. Variation in antigenic determinants specific to the infective stage of Trypanosoma cruzi. Infect. Immun. 2:1986;235-239.
58. Wysocki L. J., Sato V. Panning for lymphocytes: A method for cell selection. Proc. Natl. Acad. Sci. USA. 75:1978;2844-2848.
59. Zinkernagel R., Doherty P. Major transplantation antigens, viruses and specificity of surveillance T cells. Contemp. Topics Immunol. 7:1977;179-220.